Autonomix medical, inc. announces abstract highlighting preliminary positive clinical results accepted at the society of interventional oncology (sio) 2025 annual scientific meeting

The woodlands, tx, jan. 13, 2025 (globe newswire) -- autonomix medical, inc. (nasdaq: amix) (“autonomix” or the “company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the sio 2025 annual scientific meeting, being held january 30 – february 3, 2025 in las vegas, nv.
AMIX Ratings Summary
AMIX Quant Ranking